Collaboration Between UHL, UHN, and Microsoft to Enhance AI in Healthcare
UHL, UHN, and Microsoft partner to advance AI in healthcare, aiming to improve patient care and streamline services. π€π»
July 31, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 𧬠Rare Diseases.
The Artificial Intelligence-Assisted Diagnosis of Skeletal Dysplasias in Pediatric Patients: A Comparative Benchmark Study of Large Language Models and a Clinical Expert Group.
AI models show 62.2% accuracy in diagnosing skeletal dysplasias, compared to 82.2% by clinical experts. π€π
July 29, 2025
AI Enhances Clinical Trials for Alzheimer’s Drug Development
AI improves Alzheimer’s drug trials by accurately identifying patient groups, potentially speeding up effective treatment development. π§ π
July 28, 2025
New tools for diagnosis of primary immunodeficiencies: from awareness to artificial intelligence.
New diagnostic tools for primary immunodeficiencies: AI and expert-driven strategies show promise in early detection. π§¬π
July 25, 2025
Rare diseases: ethical challenges in the era of digital health.
Exploring ethical challenges in digital health for rare diseases: data integration, patient experiences, and AI implications. ππ»
July 24, 2025
AI-Driven Drug Discovery Offers Hope for Rett Syndrome Treatment
AI-driven drug discovery shows promise for Rett syndrome treatment. Vorinostat may offer new hope for affected patients. π§¬π
July 22, 2025
An academic evaluation of ChatGpt’s ability and accuracy in creating patient education resources for rare cardiovascular diseases.
ChatGPT’s accuracy in rare cardiovascular disease education is limited; expert review shows redundancy and incomplete answers. ππ
July 19, 2025
Artificial intelligence for diagnosing rare bone diseases: a global survey of healthcare professionals.
AI in Rare Bone Disease Diagnosis: 91% of healthcare professionals value imaging! π€π Concerns about AI errors persist.
July 17, 2025
Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions.
AI transforms rare disease diagnosis and treatment, addressing 3.5%-5.9% of global cases. Key advancements and challenges discussed. π€π
June 10, 2025
Letter to the Editor on “Artificial Intelligence Based Augmented Reality Navigation in Minimally Invasive Partial Nephrectomy”.
Exploring AI in minimally invasive nephrectomy: insights from Guo Q’s letter on augmented reality navigation. π€π
June 7, 2025